AnteAGE MD will launch at ACE 2020

25 Feb 2020

AnteAGE, a division of the biotech company Cellese, will release its skincare range to the UK at ACE 2020.

The company explains that AnteAGE MD is designed to start the skin’s natural regenerative processes, using a mix of synthetic human growth factors and peptides called Cytosignals, developed by the AnteAGE team. Fortified with Cytosignals, synthesised TGF- β3, anti-inflammatory stem cellstimulating defensins, and high molecular weight hyaluronic acid, the formulation aims to accelerate healing after aesthetic treatments such as laser, radiofrequency and microneedling.

Ian Sanderson, president of AnteAGE, commented, “We spent three years developing a synthetic analog which conveys all the benefits of human stem cell conditioned media – without the human cell. We are excited to launch our AnteAGE MD Growth Factor Solution and related Serum and Accelerator skincare at ACE in March.”

AnteAGE will be exhibiting at ACE on stand A11.


Log-in to post a comment